QuidelOrtho Corporation [QDEL] stock is trading at $36.46, up 41.04%. An important factor to consider is whether the stock is rising or falling in short-term value. The QDEL shares have gain 30.77% over the last week, with a monthly amount glided 39.16%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
QuidelOrtho Corporation [NASDAQ: QDEL] stock has seen the most recent analyst activity on May 08, 2025, when Jefferies upgraded its rating to a Buy but kept the price target unchanged to $44 for it. Previously, Citigroup upgraded its rating to Buy on December 11, 2024, and elevated its price target to $50. On December 10, 2024, Jefferies initiated with a Hold rating and assigned a price target of $43 on the stock. Craig Hallum upgraded its rating to a Buy and raised its price target to $57 on September 05, 2024. UBS downgraded its rating to Sell for this stock on March 04, 2024, and downed its price target to $42. In a note dated February 14, 2024, JP Morgan downgraded an Underweight rating on this stock and revised its target price from $66 to $37.
QuidelOrtho Corporation [QDEL] stock has fluctuated between $23.77 and $49.45 over the past year. Currently, Wall Street analysts expect the stock to reach $93.4 within the next 12 months. QuidelOrtho Corporation [NASDAQ: QDEL] shares were valued at $36.46 at the most recent close of the market. An investor can expect a potential return of 156.17% based on the average QDEL price forecast.
Analyzing the QDEL fundamentals
QuidelOrtho Corporation [NASDAQ:QDEL] reported sales of 2.76B for the trailing twelve months, which represents a drop of -2.38%. Gross Profit Margin for this corporation currently stands at 0.42% with Operating Profit Margin at -0.04%, Pretax Profit Margin comes in at -0.77%, and Net Profit Margin reading is -0.73%. To continue investigating profitability, this company’s Return on Assets is posted at -0.32, Equity is -0.64 and Total Capital is -0.02. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.9.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 30.92 points at the first support level, and at 25.38 for the second support level. However, for the 1st resistance point, the stock is sitting at 39.62, and for the 2nd resistance point, it is at 42.78.
Ratios To Look Out For
For context, QuidelOrtho Corporation’s Current Ratio is 1.20. On the other hand, the Quick Ratio is 0.66, and the Cash Ratio is 0.1. Considering the valuation of this stock, the price to sales ratio is 0.89, the price to book ratio is 0.82.
Transactions by insiders
Recent insider trading involved The Bujarski 2007 Trust U/A Dt, Former COO, that happened on Jan 06 ’25 when 0.1 million shares were purchased. President and CEO, Blaser Brian J. completed a deal on Dec 11 ’24 to buy 6033.0 shares. Meanwhile, Former COO Robert Bujarski bought 20000.0 shares on Dec 09 ’24.
